Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Mike Gavazzi, B.S.
Invivyd, Inc.
Disclosure(s): Invivyd, Inc.: Employee, Stocks/Bonds (Public Company)
Poster(s):
(P-2035) Pharmacokinetics (PK) and Serum Virus Neutralizing Antibody (sVNA) Titers Following the 2
nd
dose of Pemivibart in the Phase 3 CANOPY Trial
Saturday, October 19, 2024
12:15 PM – 1:30 PM
US PT